This result is consistent with our observation that in contrast to CXCL10 (which was produced predominantly by tumor-associated myeloid cells), a significant proportion of CCL5 originated from CD8+ T cells themselves in addition to the myeloid component by activated T cells. This evidence concerns the gene CCL5 and neoplasm.